Planners have no relevant financial relationships with ineligible companies to disclose related to this activity. Faculty have disclosed the following relevant financial relationships. All relevant financial relationships have been mitigated.

Faculty:	Relationship Identified With:
Fred D. Lublin, MD (Course Chair)	Consultant/Advisor: Abata Therapeutics; Actelion; Amgen Inc.; Avotres Inc.; Baim Institute for Clinical Research; Biohaven Pharmaceuticals; Biogen; BrainStorm Cell Limited; Bristol-Myers Squibb Company; Cognito Therapeutics; EMD Serono Inc.; Entelexo, Inc; F. Hoffmann-La Roche Ltd; Genentech, Inc.; Hexal AG; Horizon Therapeutics; ImmPACT Bio; Immunic Therapeutics; InnoCare Pharma; Janssen Pharmaceuticals; LabCorp; LAPIX Therapeutics; Mapi Pharma; NeuraLight; Neurogene Inc.; Novartis AG; Sandoz AG; Sanofi Genzyme; SetPoint Medical; Sudo Biosciences, Inc.; Viatris Inc. Grant/Research Support: Biogen; BrainStorm Cell Limited; National Institutes of Health; National Multiple Sclerosis Society; Sanofi Genzyme Stock Options: Avotres Inc.; Entelexo, Inc; LAPIX Therapeutics; NeuraLight Speaker’s Bureau: Sanofi Genzyme
Joseph Berger, MD	Consultant/Advisor: Bristol-Myers Squibb Company; Celgene Corporation; Cycle Pharma; Dice Therapeutics; Excision BioTherapeutics, Inc.; F. Hoffmann-La Roche Ltd; Genentech, Inc.; Gilead Sciences, Inc.; Janssen Pharmaceuticals; Merck & Co., Inc.; Morphic Therapeutics; Novartis AG; Pfizer Inc.; Population Bio, Inc; Sandoz Group AG; Seagen; Takeda Pharmaceutical Company Limited; TG Therapeutics Grant/Research Support: Mapi Pharma Speaker’s Bureau: TG Therapeutics
Amit Bar-Or, MD	Consultant/Advisor: Abata Therapeutics; Autolus Therapeutics; Biogen; Cabaletta Bio, Inc.; Capstan Therapeutics; EMD Serono Inc.; F. Hoffmann-La Roche Ltd; Genentech, Inc.; GlaxoSmithKline; Immunic Therapeutics; Merck & Co., Inc.; Moderna; Novartis AG; Sana Biotechnology; Sangamo Therapeutics, Inc.; Sanofi Genzyme; Viracta Therapeutics, Inc. Grant/Research Support: Biogen; EMD Serono Inc.; F. Hoffmann-La Roche Ltd; Genentech, Inc.; Merck & Co., Inc.; Novartis AG
Peter Calabresi, MD	Consultant/Advisor: Lilly; Novartis AG Grant/Research Support: Genentech, Inc.
Jeffrey Cohen, MD	Consultant/Advisor: Astoria; Bristol-Myers Squibb Company; Convelo Therapeutics; Viatris Inc. Grant/Research Support: Celltrion Healthcare
Fiona Costello, MD	Consultant/Advisor: Amgen Inc.; Horizon Therapeutics; Novartis AG; Sanofi Genzyme Speaker’s Bureau: Amgen Inc.; Horizon Therapeutics; Novartis AG; Sanofi Genzyme
Patricia Coyle, MD	Consultant/Advisor: Accordant; Amgen Inc.; EMD Serono Inc.; F. Hoffmann-La Roche Ltd; Genentech, Inc.; GlaxoSmithKline; Horizon Therapeutics; Janssen Pharmaceuticals; Lilly; Novartis AG; Sanofi Genzyme; Viatris Inc. Grant/Research Support: Celgene Corporation; Cleveland Clinic; F. Hoffmann-La Roche Ltd; Genentech, Inc.; National Institute of Neurological Disorders and Stroke; Sanofi Genzyme
Mark Freedman, MD	Consultant/Advisor: Actelion; Alexion Pharmaceuticals, Inc.; Amgen Inc.; AstraZeneca; Atara Biotherapeutics, Inc.; Bayer AG; Biogen; Celestra Health Systems; EMD Serono Inc.; F. Hoffmann-La Roche Ltd; Find Therapeutics; Horizon Therapeutics; Merck & Co., Inc.; NeuroGenesis; Novartis AG; Sandoz Group AG; Sanofi Genzyme; Sentrex Health Solutions; SetPoint Medical; Teva Pharmaceutical Industries Ltd. Grant/Research Support: Sanofi Genzyme Speaker’s Bureau: EMD Serono Inc.; F. Hoffmann-La Roche Ltd; Novartis AG
Benjamin Greenberg, MD	Consultant/Advisor: Amgen Inc.; Arialys Therapeutics; Clene Inc.; EMD Serono Inc.; F. Hoffmann-La Roche Ltd; Genentech, Inc.; GenrAb; IQVIA; Novartis AG; Regeneron Pharmaceuticals Inc.; Sandoz AG; Sanofi Genzyme; Signant Health; Syneos Health; TG Therapeutics Grant/Research Support: Anokion Equity Holder: Clene Inc.; GenrAb
Stephen Krieger, MD	Consultant/Advisor: Baim Institute; Biogen; Cleveland Clinic; Cycle Pharmaceuticals Limited; EMD Serono Inc.; Genentech, Inc.; MedRx; Novartis AG; Octave Bioscience, Inc; Sanofi Genzyme; TG Therapeutics Grant/Research Support: Biogen; Bristol-Myers Squibb Company; Novartis AG; Sanofi Genzyme Speaker’s Bureau: Biogen; EMD Serono Inc.; Genentech, Inc.; TG Therapeutics
Erin Longbrake, MD, PhD	Consultant/Advisor: Alexion Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; EMD Serono Inc.; Genentech, Inc.; Novartis AG; TG Therapeutics Grant/Research Support: Biogen; Genentech, Inc.; Intus Bioscience
Clyde Markowitz, MD	Consultant/Advisor: Amgen Inc.; Bristol-Myers Squibb Company; EMD Serono Inc.; F. Hoffmann-La Roche Ltd; Genentech, Inc.; Horizon Therapeutics; Immunic Therapeutics; Novartis AG; Sanofi Genzyme; TG Therapeutics
Aaron Miller, MD	Consultant/Advisor: Accordant; Biogen; CorEvitas, LLC; Mapi Pharma; Verana Health; Viatris Inc. Grant/Research Support: Sanofi Genzyme Speaker’s Bureau: Alexion Pharmaceuticals, Inc.; AstraZeneca; Biogen; Horizon Therapeutics
Robert T. Naismith, MD	Consultant/Advisor: Alexion Pharmaceuticals, Inc.; Amgen Inc.; Astoria; Biogen; Bristol-Myers Squibb Company; Celltrion Healthcare; EMD Serono Inc.; Genentech, Inc.; ImmPACT Bio; Kyverna Therapeutics Inc; Novartis AG; Sandoz Group AG; Sanofi Genzyme; TG Therapeutics
Daniel Ontaneda, MD, PhD	Consultant/Advisor: Bristol-Myers Squibb Company; Contineum Therapeutics; F. Hoffmann-La Roche Ltd; Genentech, Inc.; Novartis AG Grant/Research Support: Bristol-Myers Squibb Company; Genentech, Inc.; F. Hoffmann-La Roche Ltd
Amy Perrin Ross, APN, MSN, CNRN, MSCN	Consultant/Advisor: Alexion Pharmaceuticals, Inc.; Amgen Inc.; Bristol-Myers Squibb Company; EMD Serono Inc.; F. Hoffmann-La Roche Ltd; Novartis AG; Sandoz AG; TG Therapeutics; UCB S.A., Belgium
Daniel Reich, MD, PhD	Grant/Research Support: Abata Therapeutics; Sanofi Genzyme